{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:58:50Z","timestamp":1791644330220,"version":"4.3.4"},"reference-count":307,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bbadis.2025.168143","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T22:42:14Z","timestamp":1766356934000},"page":"168143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting the NLRP3 inflammasome signalling in acute myeloid leukemia: Mechanisms, therapeutics, and future directions"],"prefix":"10.1016","volume":"1872","author":[{"given":"Sally H.","family":"Fayad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Mohamed","family":"Salah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayad A.","family":"Jaffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Darwiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbadis.2025.168143_bb0005","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ajh.26822","article-title":"Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Shimony","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.bbadis.2025.168143_bb0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000536152","article-title":"Pathophysiology of acute myeloid leukemia","volume":"147","author":"Wachter","year":"2024","journal-title":"Acta Haematol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/s43042-024-00563-w","article-title":"Prognosis and treatment in acute myeloid leukemia: a comprehensive review","volume":"25","author":"Debnath","year":"2024","journal-title":"Egypt. J. Med. Human Genet."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-024-00649-y","article-title":"Global, regional, and national burden of acute myeloid leukemia, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"12","author":"Zhou","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bbadis.2025.168143_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116706","article-title":"Sulforaphane decreases oxidative stress and inhibits NLRP3 inflammasome activation in a mouse model of ulcerative colitis","volume":"175","author":"Zhou","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0030","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.genom.3.032802.115046","article-title":"Genetics of myeloid leukemias","volume":"3","author":"Kelly","year":"2002","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"issue":"22","key":"10.1016\/j.bbadis.2025.168143_bb0040","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bbadis.2025.168143_bb0045","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","article-title":"Recurring mutations found by sequencing an acute myeloid leukemia genome","volume":"361","author":"Mardis","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nm.4439","article-title":"The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions","volume":"24","author":"Bolouri","year":"2017","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1248\/bpb.b18-00522","article-title":"Polydatin regulates the apoptosis and autophagy of fibroblasts obtained from patients with ankylosing spondylitis","volume":"42","author":"Ma","year":"2018","journal-title":"Biol. Pharm. Bull."},{"issue":"12","key":"10.1016\/j.bbadis.2025.168143_bb0060","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2025.168143_bb0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41408-024-01143-2","article-title":"Current status and research directions in acute myeloid leukemia","volume":"14","author":"Kantarjian","year":"2024","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-024-01033-7","article-title":"Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century","volume":"14","author":"Hemminki","year":"2024","journal-title":"Blood Cancer J."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb0075","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/2159-8290.CD-19-1011","article-title":"Advances in the treatment of acute myeloid leukemia: new drugs and new challenges","volume":"10","author":"Short","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbadis.2025.168143_bb0080","series-title":"Hematologic Malignancies","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-030-72676-8_11","article-title":"Treatment of relapsed and refractory AML: intensive approach in fit patients","author":"Jaramillo","year":"2021"},{"issue":"8","key":"10.1016\/j.bbadis.2025.168143_bb0085","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41591-018-0115-6","article-title":"Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib","volume":"24","author":"Quek","year":"2018","journal-title":"Nat. Med."},{"issue":"22","key":"10.1016\/j.bbadis.2025.168143_bb0090","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood.2020007626","article-title":"Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin","volume":"137","author":"Schmalbrock","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/ijms26010071","article-title":"Advances in DNA\/RNA sequencing and their applications in acute myeloid leukemia (AML)","volume":"26","author":"Ahmed","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb0100","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41375-018-0326-3","article-title":"CD34+CD38\u2212 leukemic stem cell frequency to predict outcome in acute myeloid leukemia","volume":"33","author":"Zeijlemaker","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.bbadis.2025.168143_bb0105","article-title":"The NLRP3 inflammasome and its role in acute myeloid leukemia onset and development","author":"De Macedo","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbadis.2025.168143_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.1610136","article-title":"Inflammation in focus: the beginning and the end","volume":"27","author":"Kiss","year":"2022","journal-title":"Pathol. Oncol. Res."},{"issue":"8","key":"10.1016\/j.bbadis.2025.168143_bb0115","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/febs.16693","article-title":"Regenerative inflammation: when immune cells help to re-build tissues","volume":"291","author":"Caballero-S\u00e1nchez","year":"2022","journal-title":"FEBS J."},{"issue":"S2","key":"10.1016\/j.bbadis.2025.168143_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s13223-018-0278-1","article-title":"An introduction to immunology and immunopathology","volume":"14","author":"Marshall","year":"2018","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb0125","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.immuni.2024.03.007","article-title":"The conceptual foundations of innate immunity: taking stock 30\u00a0years later","volume":"57","author":"Pradeu","year":"2024","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb0130","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/08820139.2024.2334296","article-title":"Immune dysregulation in chronic obstructive pulmonary disease","volume":"53","author":"Pang","year":"2024","journal-title":"Immunol. Investig."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0135","article-title":"Immune-mediated tissue injury (hypersensitivity reactions)","volume":"1","author":"Prud\u2019homme","year":"2020","journal-title":"McGill J. Med."},{"key":"10.1016\/j.bbadis.2025.168143_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1385479","article-title":"Inflammation and cancer: friend or foe?","volume":"15","author":"Turizo-Smith","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0145","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Sign. Transduct. Target Ther."},{"key":"10.1016\/j.bbadis.2025.168143_bb0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2017.01.014","article-title":"Pattern recognitions receptors in immunodeficiency disorders","volume":"808","author":"Mortaz","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbadis.2025.168143_bb0155","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41577-024-01027-3","article-title":"DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways","volume":"24","author":"Huang","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.965726","article-title":"Link between sterile inflammation and cardiovascular diseases: focus on cGAS-STING pathway in the pathogenesis and therapeutic prospect","volume":"9","author":"Du","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb0165","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00281-014-0434-8","article-title":"Beyond canonical inflammasomes: emerging pathways in IL-1-mediated autoinflammatory disease","volume":"36","author":"Lukens","year":"2014","journal-title":"Semin. Immunopathol."},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb0170","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0175","first-page":"27","article-title":"An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia","volume":"4","author":"Lasry","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbadis.2025.168143_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5584492","article-title":"Insights regarding the role of inflammasomes in leukemia: what do we know?","volume":"2023","author":"Alves-Hanna","year":"2023","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bbadis.2025.168143_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1347402","article-title":"Inflammation as a driver of hematological malignancies","volume":"14","author":"Saluja","year":"2024","journal-title":"Front. Oncol."},{"issue":"13","key":"10.1016\/j.bbadis.2025.168143_bb0190","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1016\/j.celrep.2017.03.018","article-title":"Identification of interleukin-1 by functional screening as a key mediator of cellular expansion and disease progression in acute myeloid leukemia","volume":"18","author":"Carey","year":"2017","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb0195","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41375-024-02136-7","article-title":"Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche","volume":"38","author":"Chen","year":"2024","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb0200","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.stem.2016.08.021","article-title":"Mesenchymal inflammation drives genotoxic stress in hematopoietic stem cells and predicts disease evolution in human pre-leukemia","volume":"19","author":"Zambetti","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbadis.2025.168143_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.825611","article-title":"Inflammasome activation in myeloid malignancies\u2014friend or foe?","volume":"9","author":"Andina","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.bbadis.2025.168143_bb0210","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2025.168143_bb0215","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.bbadis.2025.168143_bb0220","article-title":"The NLRP3 inflammasome in inflammatory diseases: cellular dynamics and role in granuloma formation","volume":"411\u2013412","author":"De Oliveira","year":"2025","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0225","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13045-023-01407-7","article-title":"Involvement of inflammasomes in tumor microenvironment and tumor therapies","volume":"16","author":"Zhang","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1195572","article-title":"The roles of inflammasomes in cancer","volume":"14","author":"Deng","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0235","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.abb.2019.02.008","article-title":"NOD-like receptors and inflammasomes: a review of their canonical and non-canonical signaling pathways","volume":"670","author":"Platnich","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.bbadis.2025.168143_bb0240","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3390\/ijms22031271","article-title":"The NLRP3 inflammasome and its role in the pathogenicity of leukemia","volume":"22","author":"Urwanisch","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bbadis.2025.168143_bb0245","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0250","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41467-020-15497-1","article-title":"Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb0255","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s43450-023-00502-7","article-title":"Calycosin induces ferroptosis by SLC7A11 through the PI3K\/AKT pathway in acute myelocytic leukemia","volume":"34","author":"Xu","year":"2024","journal-title":"Rev. Bras. Farmacogn."},{"key":"10.1016\/j.bbadis.2025.168143_bb0260","article-title":"NLRP3 inflammasome promotes the progression of acute myeloid leukemia via IL-1\u03b2 pathway","volume":"12","author":"Zhong","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-025-01284-9","article-title":"Updated insights into the molecular networks for NLRP3 inflammasome activation","author":"Paik","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fceld.2024.1503799","article-title":"Regulation of pyroptosis by NF-\u03baB signaling","volume":"3","author":"Yang","year":"2025","journal-title":"Front. Cell Death"},{"key":"10.1016\/j.bbadis.2025.168143_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases","volume":"14","author":"Blevins","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 receptor in infection and inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2025.168143_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115621","article-title":"Polydatin protects against calcium oxalate crystal-induced renal injury through the cytoplasmic\/mitochondrial reactive oxygen species-NLRP3 inflammasome pathway","volume":"167","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.bbadis.2025.168143_bb0290","first-page":"2345","article-title":"Nrf2 and oxidative stress: a general overview of mechanisms and implications in human disease","volume":"11","author":"Ngo","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.bbadis.2025.168143_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174824","article-title":"Sulforaphane regulates the proliferation of leukemia stem-like cells via sonic hedgehog signaling pathway","volume":"919","author":"Wang","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110229","article-title":"Parthenolide targets NLRP3 to treat inflammasome-related diseases","volume":"119","author":"Liu","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0305","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jcph.1730","article-title":"CD33-targeted therapies: beating the disease or beaten to death?","volume":"61","author":"Maakaron","year":"2021","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2016.00151","article-title":"Unraveling the pathogenesis of MDS: the NLRP3 inflammasome and pyroptosis drive the MDS phenotype","volume":"6","author":"Sallman","year":"2016","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb0315","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-05786-0","article-title":"Cathepsin B in programmed cell death machinery: mechanisms of execution and regulatory pathways","volume":"14","author":"Xie","year":"2023","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.bbadis.2025.168143_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114609","article-title":"FDA-approved disulfiram inhibits the NLRP3 inflammasome by regulating NLRP3 palmitoylation","volume":"43","author":"Xu","year":"2024","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.bbadis.2025.168143_bb0325","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Mu\u00f1oz-Planillo","year":"2013","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb0330","article-title":"Sterile inflammation and the NLRP3 inflammasome in cardiometabolic disease","volume":"46","author":"Cho","year":"2023","journal-title":"Biom. J."},{"key":"10.1016\/j.bbadis.2025.168143_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00721","article-title":"Caffeic acid phenethyl ester prevents colitis-associated cancer by inhibiting NLRP3 inflammasome","volume":"10","author":"Dai","year":"2020","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.bbadis.2025.168143_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114516","article-title":"Fatty acid synthesis promotes inflammasome activation through NLRP3 palmitoylation","volume":"43","author":"Leishman","year":"2024","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0345","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/imm.13267","article-title":"Inhibition of the NLRP3 inflammasome by HSP90 inhibitors","volume":"162","author":"Nizami","year":"2021","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0350","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.1038\/s41598-018-25123-2","article-title":"Hsp90 inhibition as a means to inhibit activation of the NLRP3 inflammasome","volume":"8","author":"Piippo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.168143_bb0355","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb0360","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140242","article-title":"Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models","volume":"131","author":"He","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.bbadis.2025.168143_bb0365","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.3390\/genes13122281","article-title":"A novel defined pyroptosis-related gene signature for the prognosis of acute myeloid leukemia","volume":"13","author":"Huang","year":"2022","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0370","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2025.168143_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1459025","article-title":"The role of PI3K signaling pathway in Alzheimer\u2019s disease","volume":"16","author":"Pan","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbadis.2025.168143_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116649","article-title":"Ziprasidone triggers inflammasome signaling via PI3K-Akt-mTOR pathway to promote atrial fibrillation","volume":"175","author":"Lu","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb0385","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1538\/expanim.21-0002","article-title":"PI3K regulates the activation of NLRP3 inflammasome in atherosclerosis through part-dependent AKT signaling pathway","volume":"70","author":"Liu","year":"2021","journal-title":"Exp. Anim."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0390","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13045-022-01262-y","article-title":"The dual role of autophagy in acute myeloid leukemia","volume":"15","author":"Seo","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0395","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"11","key":"10.1016\/j.bbadis.2025.168143_bb0400","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011254","article-title":"MAP kinase pathways","volume":"4","author":"Morrison","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"9","key":"10.1016\/j.bbadis.2025.168143_bb0405","doi-asserted-by":"crossref","first-page":"14951","DOI":"10.1002\/jcp.28334","article-title":"RAS\/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression","volume":"234","author":"Rezatabar","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0410","doi-asserted-by":"crossref","DOI":"10.1038\/srep39303","article-title":"Surfactin inducing mitochondria-dependent ROS to activate MAPKs, NF-\u03baB and inflammasomes in macrophages for adjuvant activity","volume":"6","author":"Gan","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bbadis.2025.168143_bb0415","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.7150\/ijbs.34211","article-title":"Caffeine inhibits NLRP3 inflammasome activation by suppressing MAPK\/NF-\u03baB and A2aR signaling in LPS-induced THP-1 macrophages","volume":"15","author":"Zhao","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"18","key":"10.1016\/j.bbadis.2025.168143_bb0420","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.3390\/ijms22189952","article-title":"Acute glucose shift induces the activation of the NLRP3 inflammasome in THP-1 cells","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.168143_bb0425","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.molimm.2020.02.017","article-title":"\u03b2-Catenin promotes NLRP3 inflammasome activation via increasing the association between NLRP3 and ASC","volume":"121","author":"Huang","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00378","article-title":"Crosstalk between Wnt\/\u03b2-catenin and NF-\u03baB signaling pathway during inflammation","volume":"7","author":"Ma","year":"2016","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.bbadis.2025.168143_bb0435","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.3390\/ijms21176204","article-title":"The role of NLRP3 inflammasome in the pathogenesis of traumatic brain injury","volume":"21","author":"Irrera","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.bbadis.2025.168143_bb0440","doi-asserted-by":"crossref","first-page":"24270","DOI":"10.18632\/aging.202143","article-title":"Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK\/NLRP3 inflammasome pathway","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.bbadis.2025.168143_bb0445","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00597","article-title":"ATP-induced inflammasome activation and pyroptosis is regulated by AMP-activated protein kinase in macrophages","volume":"7","author":"Zha","year":"2016","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb0450","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10753-021-01439-6","article-title":"The signaling pathways regulating NLRP3 inflammasome activation","volume":"44","author":"Chen","year":"2021","journal-title":"Inflammation"},{"issue":"12","key":"10.1016\/j.bbadis.2025.168143_bb0455","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3390\/antiox11122377","article-title":"Nrf2 regulates oxidative stress and its role in cerebral ischemic stroke","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxidants"},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb0460","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0465","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.redox.2017.03.001","article-title":"Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK\/GSK3\u03b2-Nrf2 signal axis","volume":"12","author":"Lv","year":"2017","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0470","doi-asserted-by":"crossref","first-page":"10147","DOI":"10.1038\/s41598-019-46657-z","article-title":"LC3-positive structures are prominent in autophagy-deficient cells","volume":"9","author":"Runwal","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.168143_bb0475","article-title":"The role of the effects of autophagy on NLRP3 inflammasome in inflammatory nervous system diseases","volume":"9","author":"Zhao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.591803","article-title":"Interplay between NLRP3 inflammasome and autophagy","volume":"11","author":"Biasizzo","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0485","first-page":"1","article-title":"Emerging mechanisms of pyroptosis and its therapeutic strategy in cancer","volume":"8","author":"Lu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0490","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-065X.2012.01157.x","article-title":"LKB1 and AMPK: central regulators of lymphocyte metabolism and function","volume":"249","author":"Blagih","year":"2012","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.bbadis.2025.168143_bb0495","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1083\/jcb.201503023","article-title":"TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity","volume":"210","author":"Kimura","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0500","article-title":"How PPAR-alpha mediated inflammation may affect the pathophysiology of chronic kidney disease","volume":"8","author":"Masenga","year":"2024","journal-title":"Curr. Res. Physiol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0505","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6386729","article-title":"PPAR-\u03b3 activation exerts an anti-inflammatory effect by suppressing the NLRP3 inflammasome in spinal cord-derived neurons","volume":"2019","author":"Meng","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbadis.2025.168143_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119196","article-title":"Identification of GL-V9 as a novel senolytic agent against senescent breast cancer cells","volume":"272","author":"Yang","year":"2021","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.bbadis.2025.168143_bb0515","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/SHK.0000000000001137","article-title":"Involvement of TLR4 and PPAR-\u03b1 receptors in host response and NLRP3 inflammasome activation, against pulmonary infection with Pseudomonas aeruginosa","volume":"51","author":"Gugliandolo","year":"2019","journal-title":"Shock (Augusta, GA)"},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0520","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1038\/s41467-020-19554-7","article-title":"Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to PPARA agonism and fasting","volume":"11","author":"Brocker","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0525","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12964-024-01777-6","article-title":"Targeting NLRP3 inhibits AML progression by inducing PERK\/eIF2-mediated apoptosis","volume":"22","author":"Luciano","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0530","first-page":"1","article-title":"Crosstalk between autophagy and metabolism: implications for cell survival in acute myeloid leukemia","volume":"10","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2025.168143_bb0535","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1018848","article-title":"Interaction between autophagy and the NLRP3 inflammasome in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"14","author":"Lu","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbadis.2025.168143_bb0540","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1109938","article-title":"The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors","volume":"13","author":"Zhan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0545","article-title":"A review: PI3K\/AKT\/mTOR signaling pathway and its regulated eukaryotic translation initiation factors may be a potential therapeutic target in esophageal squamous cell carcinoma","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0550","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12929-021-00724-8","article-title":"NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer","volume":"28","author":"Faria","year":"2021","journal-title":"J. Biomed. Sci."},{"issue":"3","key":"10.1016\/j.bbadis.2025.168143_bb0555","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/acs.chemrestox.2c00044","article-title":"Necrosulfonamide selectively induces DNA double-strand breaks in acute myeloid leukemia cells","volume":"35","author":"Chen","year":"2022","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.bbadis.2025.168143_bb0560","first-page":"121","article-title":"Formononetin and dihydroartemisinin act synergistically to induce apoptosis in human acute myeloid leukemia cell lines","volume":"26","author":"Abbasi","year":"2024","journal-title":"Cell J. (Yakhteh)"},{"key":"10.1016\/j.bbadis.2025.168143_bb0565","first-page":"1","article-title":"Potential anticancer properties and mechanisms of action of formononetin","volume":"2019","author":"Jiang","year":"2019","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0570","article-title":"Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome","volume":"31","author":"Liu","year":"2025","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2025.168143_bb0575","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bbrc.2020.02.147","article-title":"Formononetin ameliorates myocardial ischemia\/reperfusion injury in rats by suppressing the ROS-TXNIP-NLRP3 pathway","volume":"525","author":"Wang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2025.168143_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117239","article-title":"Formononetin ameliorates DSS-induced colitis by inhibiting the MAPK\/PPAR-\u03b3\/NF-\u03baB\/ROS signaling pathways","author":"Cao","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbadis.2025.168143_bb0585","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0024-3205(97)00365-2","article-title":"Effects of biochanin A on the growth and differentiation of myeloid leukemia WEHI-3B (JCS) cells","volume":"61","author":"Fung","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2025.168143_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109711","article-title":"Neuroprotection impact of biochanin A against pentylenetetrazol-kindled mice: targeting NLRP3 inflammasome\/TXNIP pathway and autophagy modulation","volume":"115","author":"El-Sayed","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb0595","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3390\/antiox12051052","article-title":"Biochanin A ameliorates nephropathy in High-Fat Diet\/Streptozotocin-induced diabetic rats: effects on NF-KB\/NLRP3 axis, pyroptosis, and fibrosis","volume":"12","author":"Ram","year":"2023","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.bbadis.2025.168143_bb0600","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23738","article-title":"Biochanin A mitigates ulcerative colitis and intestinal inflammation in mice by inhibiting MAPK\/NF-kB (p65) axis","volume":"38","author":"Kulhari","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106246","article-title":"Biochanin A as a modulator of the inflammatory response: an updated overview and therapeutic potential","volume":"180","author":"Felix","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbadis.2025.168143_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107623","article-title":"Sepsis-induced acute lung injury in young rats is relieved by calycosin through inactivating the HMGB1\/MyD88\/NF-\u03baB pathway and NLRP3 inflammasome","volume":"96","author":"Chen","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0615","article-title":"Calycosin attenuates renal ischemia\/reperfusion injury by suppressing NF-\u03baB mediated inflammation via PPAR\u03b3\/EGR1 pathway","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbadis.2025.168143_bb0620","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/cas.12988","article-title":"Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression","volume":"107","author":"Okamoto","year":"2016","journal-title":"Cancer Sci."},{"issue":"24","key":"10.1016\/j.bbadis.2025.168143_bb0625","doi-asserted-by":"crossref","first-page":"7696","DOI":"10.3390\/molecules26247696","article-title":"Withaferin A: from ancient remedy to potential drug candidate","volume":"26","author":"Sultana","year":"2021","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb0630","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1734-1140(09)70125-2","article-title":"Circadian time-dependent chemopreventive potential of withaferin-A in 7,12-dimethyl-benz [a]anthracene-induced oral carcinogenesis","volume":"61","author":"Manoharan","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbadis.2025.168143_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00195","article-title":"Withaferin a associated differential regulation of inflammatory cytokines","volume":"9","author":"Dubey","year":"2018","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.bbadis.2025.168143_bb0640","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1253\/circj.CJ-18-1391","article-title":"Withaferin A prevents myocardial ischemia\/reperfusion injury by upregulating AMP-activated protein kinase-dependent B-cell lymphoma2 signaling","volume":"83","author":"Guo","year":"2019","journal-title":"Circ. J."},{"issue":"2","key":"10.1016\/j.bbadis.2025.168143_bb0645","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-03243-w","article-title":"Withaferin A alleviates fulminant hepatitis by targeting macrophage and NLRP3","volume":"12","author":"Xia","year":"2021","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb0650","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bcp.2014.08.004","article-title":"Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKK\u03b2","volume":"91","author":"Heyninck","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0655","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2147\/CMAR.S160924","article-title":"Andrographolide potentiates the antitumor effect of topotecan in acute myeloid leukemia cells through an intrinsic apoptotic pathway","volume":"10","author":"Hodroj","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"62","key":"10.1016\/j.bbadis.2025.168143_bb0660","first-page":"135","article-title":"14-Deoxy-11,12-didehydroandrographolide: a novel compound isolated from Andrographis paniculata Nees. induces robust apoptosis in leukemic cells","volume":"15","author":"Sarkar","year":"2019","journal-title":"Pharmacogn. Mag."},{"key":"10.1016\/j.bbadis.2025.168143_bb0665","article-title":"Jiyuan oridonin A induces differentiation of acute myeloid leukemia cells including leukemic stem-like cells","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0670","article-title":"Andrographolide inhibits IL-1\u03b2 release in bone marrow-derived macrophages and monocyte infiltration in mouse knee joints induced by monosodium urate","volume":"410","author":"Lo","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbadis.2025.168143_bb0675","doi-asserted-by":"crossref","first-page":"764","DOI":"10.21037\/atm-20-7973","article-title":"Andrographolide alleviates bleomycin-induced NLRP3 inflammasome activation and epithelial-mesenchymal transition in lung epithelial cells by suppressing AKT\/mTOR signaling pathway","volume":"9","author":"Li","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bbadis.2025.168143_bb0680","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbi.2020.09.017","article-title":"Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease","volume":"91","author":"Ahmed","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbadis.2025.168143_bb0685","doi-asserted-by":"crossref","first-page":"542","DOI":"10.12688\/f1000research.53595.3","article-title":"Andrographolide, isolated from Andrographis paniculata, induces apoptosis in monocytic leukemia and multiple myeloma cells via augmentation of reactive oxygen species production","volume":"10","author":"Doi","year":"2022","journal-title":"F1000Research"},{"issue":"9","key":"10.1016\/j.bbadis.2025.168143_bb0690","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3390\/molecules22091444","article-title":"Andrographolide suppresses MV4-11 cell proliferation through the inhibition of FLT3 signaling, fatty acid synthesis and cellular Iron uptake","volume":"22","author":"Chen","year":"2017","journal-title":"Molecules"},{"issue":"9\u201310","key":"10.1016\/j.bbadis.2025.168143_bb0695","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.lfs.2010.12.019","article-title":"Andrographolide and 14-deoxy-11,12-didehydroandrographolide inhibit cytochrome P450s in HepG2 hepatoma cells","volume":"88","author":"Ooi","year":"2011","journal-title":"Life Sci."},{"issue":"20","key":"10.1016\/j.bbadis.2025.168143_bb0700","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.3390\/molecules25204830","article-title":"Screening of an endophyte transforming polydatin to resveratrol from Reynoutria japonica Houtt and the optimization of its transformation parameters","volume":"25","author":"Liu","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bbadis.2025.168143_bb0705","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11418-014-0815-2","article-title":"14-Deoxy-11,12-didehydroandrographolide inhibits proliferation and induces GSH-dependent cell death of human promonocytic leukemic cells","volume":"68","author":"Raghavan","year":"2014","journal-title":"J. Nat. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0710","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-024-09493-7","article-title":"Interaction of olive oil-based propolis and caffeic acid phenethyl ester with methylprednisolone used in the treatment of human acute myeloid leukemia","volume":"51","author":"Dogan","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"8","key":"10.1016\/j.bbadis.2025.168143_bb0715","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/antiox12081500","article-title":"Caffeic acid phenethyl ester (CAPE): biosynthesis, derivatives and formulations with neuroprotective activities","volume":"12","author":"P\u00e9rez","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbadis.2025.168143_bb0720","article-title":"Caffeic acid phenethyl ester ameliorates calcification by inhibiting activation of the AKT\/NF-\u039aB\/NLRP3 inflammasome pathway in human aortic valve interstitial cells","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0725","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/09637486.2013.832174","article-title":"Theoretical, antioxidant and cytotoxic activities of caffeic acid phenethyl ester and chrysin","volume":"65","author":"Sulaiman","year":"2013","journal-title":"Int. J. Food Sci. Nutr."},{"issue":"22","key":"10.1016\/j.bbadis.2025.168143_bb0730","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1182\/blood.V114.22.4802.4802","article-title":"Caffeic acid phenethyl ester induces apoptosis in acute myeloid leukemia cells \u2014 possible role of Chemokine\/G-Protein signaling","volume":"114","author":"Scheucher","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0735","doi-asserted-by":"crossref","DOI":"10.1593\/tlo.08202","article-title":"Caffeic acid phenylethyl ester and MG-132 have apoptotic and antiproliferative effects on leukemic cells but not on normal mononuclear cells","volume":"2","author":"Cavaliere","year":"2009","journal-title":"Transl. Oncol."},{"issue":"21","key":"10.1016\/j.bbadis.2025.168143_bb0740","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1182\/blood.V116.21.3274.3274","article-title":"Caffeic acid phenetyl ester, a Brazilian-Green-Propolis derivative, induces apoptosis in AML cells, promotes up regulation of G-protein signaling and hyper secretion of IL-8","volume":"116","author":"Scheucher","year":"2010","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.bbadis.2025.168143_bb0745","doi-asserted-by":"crossref","first-page":"8757","DOI":"10.1021\/jm301064b","article-title":"Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells","volume":"55","author":"Zhang","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2025.168143_bb0750","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cbi.2015.08.015","article-title":"Arglabin: from isolation to antitumor evaluation","volume":"240","author":"Lone","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbadis.2025.168143_bb0755","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.fitote.2015.11.018","article-title":"Chemical modification of arglabin and biological activity of its new derivatives","volume":"110","author":"Adekenov","year":"2015","journal-title":"Fitoterapia"},{"issue":"12","key":"10.1016\/j.bbadis.2025.168143_bb0760","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.114.013730","article-title":"Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in APOE 2.Ki mice fed a high-fat diet","volume":"131","author":"Abderrazak","year":"2015","journal-title":"Circulation"},{"issue":"B","key":"10.1016\/j.bbadis.2025.168143_bb0765","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3889\/oamjms.2023.11114","article-title":"Cytotoxicity and antitumor activity of arglabin and its derivatives","volume":"11","author":"Adekenov","year":"2023","journal-title":"Open Access Maced. J. Med. Sci."},{"issue":"6","key":"10.1016\/j.bbadis.2025.168143_bb0770","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/aps.2014.25","article-title":"Oridonin induces NPM mutant protein translocation and apoptosis in NPM1c+ acute myeloid leukemia cells in vitro","volume":"35","author":"Li","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb0775","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1002\/fsn3.3986","article-title":"Oridonin from Rabdosia rubescens: an emerging potential in cancer therapy \u2014 a comprehensive review","volume":"12","author":"Ali","year":"2024","journal-title":"Food Sci. Nutr."},{"issue":"40","key":"10.1016\/j.bbadis.2025.168143_bb0780","doi-asserted-by":"crossref","first-page":"68153","DOI":"10.18632\/oncotarget.19249","article-title":"Oridonin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-induced RAW264.7 cells and acute lung injury","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0785","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.bbadis.2025.168143_bb0790","doi-asserted-by":"crossref","first-page":"26628","DOI":"10.1021\/acsomega.4c03450","article-title":"TRIP13 plays an important role in the sensitivity of leukemia cell response to sulforaphane therapy","volume":"9","author":"Liu","year":"2024","journal-title":"ACS Omega"},{"issue":"8","key":"10.1016\/j.bbadis.2025.168143_bb0795","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1182\/blood-2006-06-032250","article-title":"Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo","volume":"109","author":"Zhou","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bbadis.2025.168143_bb0800","article-title":"Oridonin synergistically enhances the pro-apoptotic effect of venetoclax on acute myeloid leukemia cells by inhibiting AKT signaling","volume":"28","author":"Chen","year":"2023","journal-title":"Front. Biosci. Landm."},{"issue":"3","key":"10.1016\/j.bbadis.2025.168143_bb0805","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11684-018-0624-1","article-title":"Homoharringtonine synergy with oridonin in treatment of t(8; 21) acute myeloid leukemia","volume":"13","author":"Zhang","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.bbadis.2025.168143_bb0810","doi-asserted-by":"crossref","DOI":"10.18502\/ijaai.v19i6.4929","article-title":"Oridonin could inhibit inflammation and T-cell immunoglobulin and Mucin-3\/Galectin-9 (TIM-3\/GAL-9) autocrine loop in the acute myeloid leukemia cell line (U937) as compared to doxorubicin","author":"Nasri","year":"2020","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb0815","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3892\/ijmm.2012.1067","article-title":"Downregulation of nucleoporin 88 and 214 induced by oridonin may protect OCIM2 acute erythroleukemia cells from apoptosis through regulation of nucleocytoplasmic transport of NF-\u03baB","volume":"30","author":"Yi","year":"2012","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb0820","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/10428190400019800","article-title":"Apoptotic effect of oridonin on NB4 cells and its mechanism","volume":"46","author":"Liu","year":"2005","journal-title":"Leuk. Lymphoma\/Leuk. Lymphoma"},{"issue":"1p1","key":"10.1016\/j.bbadis.2025.168143_bb0825","doi-asserted-by":"crossref","DOI":"10.1111\/j.1751-553X.2009.01147.x","article-title":"Apoptosis inducing and differentiation enhancement effect of oridonin on the all-trans-retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells","volume":"32","author":"Gao","year":"2009","journal-title":"Int. J. Lab. Hematol."},{"issue":"2","key":"10.1016\/j.bbadis.2025.168143_bb0830","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3892\/ijo.2015.3294","article-title":"A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells","volume":"48","author":"Shi","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"11","key":"10.1016\/j.bbadis.2025.168143_bb0835","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2004-10-4135","article-title":"The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells","volume":"105","author":"Guzman","year":"2005","journal-title":"Blood"},{"issue":"17\u201318","key":"10.1016\/j.bbadis.2025.168143_bb0840","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.drudis.2013.05.005","article-title":"Parthenolide: from plant shoots to cancer roots","volume":"18","author":"Ghantous","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbadis.2025.168143_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148482","article-title":"Nrf2\/HO-1 blocks TXNIP\/NLRP3 interaction via elimination of ROS in oxygen-glucose deprivation-induced neuronal necroptosis","volume":"1817","author":"Liu","year":"2023","journal-title":"Brain Res."},{"issue":"13","key":"10.1016\/j.bbadis.2025.168143_bb0850","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1074\/jbc.M109.082305","article-title":"Anti-inflammatory compounds parthenolide and BAY 11-7082 are direct inhibitors of the inflammasome","volume":"285","author":"Juliana","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bbadis.2025.168143_bb0855","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24112103","article-title":"Novel targeted nano-parthenolide molecule against NF-kB in acute myeloid leukemia","volume":"24","author":"Darwish","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bbadis.2025.168143_bb0860","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1021\/acs.jnatprod.7b01079","article-title":"Crystal structures and human leukemia cell apoptosis inducible activities of parthenolide analogues isolated from Piptocoma rufescens","volume":"81","author":"Ren","year":"2018","journal-title":"J. Nat. Prod."},{"issue":"42","key":"10.1016\/j.bbadis.2025.168143_bb0865","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1074\/jbc.M116.750653","article-title":"Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells","volume":"291","author":"Pei","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.bbadis.2025.168143_bb0870","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1016\/j.bmc.2015.05.037","article-title":"Synthesis and antileukemic activities of C1\u2013C10-modified parthenolide analogues","volume":"23","author":"Kempema","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbadis.2025.168143_bb0875","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lfs.2017.09.019","article-title":"Osteopontin plays a unique role in resistance of CD34+\/CD123+ human leukemia cell lines KG1a to parthenolide","volume":"189","author":"Mohammadi","year":"2017","journal-title":"Life Sci."},{"issue":"47","key":"10.1016\/j.bbadis.2025.168143_bb0880","doi-asserted-by":"crossref","first-page":"33542","DOI":"10.1074\/jbc.M113.511170","article-title":"Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells","volume":"288","author":"Pei","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.bbadis.2025.168143_bb0885","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1182\/blood-2010-04-278044","article-title":"Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways","volume":"116","author":"Hassane","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bbadis.2025.168143_bb0890","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.4238\/2015.May.12.2","article-title":"Mangiferin induces cell cycle arrest at G2\/M phase through ATR-Chk1 pathway in HL-60 leukemia cells","volume":"14","author":"Peng","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"2","key":"10.1016\/j.bbadis.2025.168143_bb0895","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00210-023-02682-4","article-title":"Pharmacological properties of mangiferin: bioavailability, mechanisms of action and clinical perspectives","volume":"397","author":"Zivkovi\u0107","year":"2023","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb0900","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00394-017-1441-z","article-title":"Mangiferin suppresses endoplasmic reticulum stress in perivascular adipose tissue and prevents insulin resistance in the endothelium","volume":"57","author":"Xu","year":"2017","journal-title":"Eur. J. Nutr."},{"issue":"20","key":"10.1016\/j.bbadis.2025.168143_bb0905","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011197","article-title":"Mangiferin represses inflammation in macrophages under a hyperglycemic environment through Nrf2 signaling","volume":"25","author":"Jayasuriya","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.168143_bb0910","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cbi.2017.04.021","article-title":"Mangiferin attenuates blast-induced traumatic brain injury via inhibiting NLRP3 inflammasome","volume":"271","author":"Fan","year":"2017","journal-title":"Chem. Biol. Interact."},{"issue":"17","key":"10.1016\/j.bbadis.2025.168143_bb0915","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710124","article-title":"Anti-inflammation and anti-pyroptosis activities of mangiferin via suppressing NF-\u03baB\/NLRP3\/GSDMD signaling cascades","volume":"23","author":"Feng","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bbadis.2025.168143_bb0920","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/aps.2013.165","article-title":"Mangiferin activates Nrf2-antioxidant response element signaling without reducing the sensitivity to etoposide of human myeloid leukemia cells in vitro","volume":"35","author":"Zhang","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb0925","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3892\/ijmm.2014.1696","article-title":"Mangiferin increases Nrf2 protein stability by inhibiting its ubiquitination and degradation in human HL60 myeloid leukemia cells","volume":"33","author":"Zhao","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2025.168143_bb0930","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12272-011-0316-8","article-title":"Mangiferin induces apoptosis by suppressing Bcl-xL and XIAP expressions and nuclear entry of NF-\u03baB in HL-60 cells","volume":"34","author":"Shoji","year":"2011","journal-title":"Arch. Pharm. Res."},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb0935","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/molecules21050574","article-title":"Celastrol induces cell apoptosis and inhibits the expression of the AML1-ETO\/C-KIT oncoprotein in t(8;21) leukemia","volume":"21","author":"Yu","year":"2016","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.bbadis.2025.168143_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114882","article-title":"Celastrol as an emerging anticancer agent: current status, challenges and therapeutic strategies","volume":"163","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"40","key":"10.1016\/j.bbadis.2025.168143_bb0945","doi-asserted-by":"crossref","first-page":"67300","DOI":"10.18632\/oncotarget.18619","article-title":"Celastrol ameliorates inflammation through inhibition of NLRP3 inflammasome activation","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2025.168143_bb0950","article-title":"Celastrol regulates the HSP90-NLRP3 interaction to alleviate rheumatoid arthritis","author":"Yang","year":"2024","journal-title":"Inflammation"},{"key":"10.1016\/j.bbadis.2025.168143_bb0955","article-title":"Celastrol ameliorates Propionibacterium acnes\/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3","volume":"80","author":"Yan","year":"2020","journal-title":"Phytomedicine"},{"issue":"9","key":"10.1016\/j.bbadis.2025.168143_bb0960","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1182\/blood-2015-09-668632","article-title":"Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb\/p300 interaction","volume":"127","author":"Uttarkar","year":"2015","journal-title":"Blood"},{"issue":"29","key":"10.1016\/j.bbadis.2025.168143_bb0965","doi-asserted-by":"crossref","first-page":"46557","DOI":"10.18632\/oncotarget.10286","article-title":"Metabolomics profiles delineate uridine deficiency contributes to mitochondria-mediated apoptosis induced by celastrol in human acute promyelocytic leukemia cells","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"24","key":"10.1016\/j.bbadis.2025.168143_bb0970","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413511","article-title":"Sulforaphane and benzyl isothiocyanate suppress cell proliferation and trigger cell cycle arrest, autophagy, and apoptosis in human AML cell line","volume":"25","author":"Bertova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.168143_bb0975","article-title":"Anticancer properties of sulforaphane: current insights at the molecular level","volume":"13","author":"Ali","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2025.168143_bb0980","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.imlet.2021.03.004","article-title":"Sulforaphane inhibits NLRP3 inflammasome activation in microglia through Nrf2-mediated miRNA alteration","volume":"233","author":"Tufekci","year":"2021","journal-title":"Immunol. Lett."},{"issue":"21","key":"10.1016\/j.bbadis.2025.168143_bb0985","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113400","article-title":"Anti-leukemic activity of Brassica-derived bioactive compounds in HL-60 myeloid leukemia cells","volume":"23","author":"N\u00fa\u00f1ez-S\u00e1nchez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbadis.2025.168143_bb0990","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s11033-018-4416-0","article-title":"Alleviating the progression of acute myeloid leukemia (AML) by sulforaphane through controlling miR-155 levels","volume":"45","author":"Koolivand","year":"2018","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb0995","first-page":"44","article-title":"The inhibitory effect of sulforaphane on the proliferation of acute myeloid leukemia cell lines through controlling miR-181a","volume":"24","author":"Koolivand","year":"2022","journal-title":"Cell J."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb1000","article-title":"Glutathione-depleting liposome adjuvant for augmenting the efficacy of a glutathione covalent inhibitor oridonin for acute myeloid leukemia therapy","volume":"22","author":"Liu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbadis.2025.168143_bb1005","article-title":"Polydatin protects against leukemia by inducing apoptosis and activating autophagy via p38-MAPK pathway","author":"Zhang","year":"2025","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"19","key":"10.1016\/j.bbadis.2025.168143_bb1010","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.3390\/molecules27196474","article-title":"Polydatin: pharmacological mechanisms, therapeutic targets, biological activities, and health benefits","volume":"27","author":"Karami","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbadis.2025.168143_bb1015","author":"Liu"},{"key":"10.1016\/j.bbadis.2025.168143_bb1020","article-title":"Polydatin-mediated inhibition of HSP90\u0391 disrupts NLRP3 complexes and alleviates acute pancreatitis","volume":"7","author":"Guo","year":"2024","journal-title":"Research"},{"issue":"6","key":"10.1016\/j.bbadis.2025.168143_bb1025","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1002\/jcb.28297","article-title":"Polydatin suppresses the development of lung inflammation and fibrosis by inhibiting activation of the NACHT domain-, leucine-rich repeat-, and pyd-containing protein 3 inflammasome and the nuclear factor-\u03baB pathway after Mycoplasma pneumoniae infection","volume":"120","author":"Tang","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb1030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/1756-185X.14463","article-title":"Polydatin protects against gouty nephropathy by inhibiting renal tubular cell pyroptosis","volume":"26","author":"Shi","year":"2022","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.bbadis.2025.168143_bb1035","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1470217","article-title":"Targeting autophagy: polydatin\u2019s role in inducing cell death in AML","volume":"15","author":"Fu","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb1040","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jbt.21779","article-title":"Polydatin induces apoptosis and inhibits growth of acute monocytic leukemia cells","volume":"30","author":"Wang","year":"2016","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bbadis.2025.168143_bb1045","unstructured":"PubChem. (n.d.). MCC950. PubChem. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/mcc950."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb1050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10753-019-01098-8","article-title":"Target of MCC950 in inhibition of NLRP3 inflammasome activation: a literature review","volume":"43","author":"Wu","year":"2019","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.bbadis.2025.168143_bb1055","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb1060","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98437-3","article-title":"The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages","volume":"11","author":"Zeng","year":"2021","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bbadis.2025.168143_bb1065","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/gerona\/glz239","article-title":"NLRP3 inflammasome inhibition by MCC950 in aged mice improves health via enhanced autophagy and PPAR\u0391 activity","volume":"75","author":"Mar\u00edn-Aguilar","year":"2019","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.bbadis.2025.168143_bb1070","unstructured":"DrugBank Online. Anakinra: Uses, Interactions, Mechanism of Action | (n.d.). DrugBank. https:\/\/go.drugbank.com\/drugs\/DB00026."},{"issue":"12","key":"10.1016\/j.bbadis.2025.168143_bb1075","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.3390\/ijms22126531","article-title":"Anakinra activates superoxide dismutase 2 to mitigate inflammasome activity","volume":"22","author":"Pariano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bbadis.2025.168143_bb1080","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1073\/pnas.1322831111","article-title":"IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans","volume":"111","author":"De Luca","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb1085","doi-asserted-by":"crossref","first-page":"8420","DOI":"10.18632\/oncotarget.14220","article-title":"Sensitizing leukemia stem cells to NF-\u03baB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling","volume":"8","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb1090","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00109-023-02414-4","article-title":"FDA-approved disulfiram as a novel treatment for aggressive leukemia","volume":"102","author":"Karsa","year":"2024","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbadis.2025.168143_bb1095","unstructured":"NCI Drug Dictionary. (n.d.). Cancer.gov. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-drug\/def\/disulfiram."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb1100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s43556-024-00179-x","article-title":"NLRP inflammasomes in health and disease","volume":"5","author":"Xu","year":"2024","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.bbadis.2025.168143_bb1105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.freeradbiomed.2020.03.007","article-title":"Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation","volume":"152","author":"Deng","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.bbadis.2025.168143_bb1110","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","article-title":"FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation","volume":"21","author":"Hu","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.168143_bb1115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177352","article-title":"Disulfiram alleviates immune-mediated liver injury by inhibiting pyroptosis in hepatocytes through the NF-\u03baB pathway","volume":"992","author":"Xiong","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.168143_bb1120","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.biopha.2018.01.109","article-title":"Disulfiram\/copper causes ROS levels alteration, cell cycle inhibition, and apoptosis in acute myeloid leukaemia cell lines with modulation in the expression of related genes","volume":"99","author":"Hassani","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.bbadis.2025.168143_bb1125","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/ijc.27482","article-title":"Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies","volume":"131","author":"Conticello","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2025.168143_bb1130","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106351","article-title":"Disulfiram\/cytarabine eradicates a subset of acute myeloid leukemia stem cells with high aldehyde dehydrogenase expression","volume":"92","author":"Yang","year":"2020","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb1135","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-017-0493-5","article-title":"Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells","volume":"36","author":"Bista","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb1140","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bcmd.2011.08.004","article-title":"Disulfiram\/copper complex activated JNK\/c-jun pathway and sensitized cytotoxicity of doxorubicin in doxorubicin resistant leukemia HL60 cells","volume":"47","author":"Xu","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbadis.2025.168143_bb1145","unstructured":"PubChem. (n.d.). Necrosulfonamide. PubChem. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Necrosulfonamide."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb1150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004820","article-title":"Toxin-induced necroptosis is a major mechanism of Staphylococcus aureus lung damage","volume":"11","author":"Kitur","year":"2015","journal-title":"PLoS Pathog."},{"issue":"26","key":"10.1016\/j.bbadis.2025.168143_bb1155","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat2738","article-title":"Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis","volume":"3","author":"Rathkey","year":"2018","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.bbadis.2025.168143_bb1160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.leukres.2013.12.017","article-title":"Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations","volume":"38","author":"Kraus","year":"2014","journal-title":"Leuk. Res."},{"issue":"10","key":"10.1016\/j.bbadis.2025.168143_bb1165","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.3390\/curroncol31100450","article-title":"Ritonavir\u2019s evolving role: a journey from antiretroviral therapy to broader medical applications","volume":"31","author":"Pereira","year":"2024","journal-title":"Curr. Oncol."},{"issue":"2","key":"10.1016\/j.bbadis.2025.168143_bb1170","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.mehy.2008.08.024","article-title":"Ritonavir and disulfiram have potential to inhibit caspase-1 mediated inflammation and reduce neurological sequelae after minor blast exposure","volume":"72","author":"Foley","year":"2008","journal-title":"Med. Hypotheses"},{"issue":"10","key":"10.1016\/j.bbadis.2025.168143_bb1175","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood.V96.10.3553","article-title":"HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells","volume":"96","author":"Ikezoe","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2025.168143_bb1180","unstructured":"MedChemExpress | A-740003 | P2X Receptor Antagonist | MedChemExpress. (n.d.). MedchemExpress.com. https:\/\/www.medchemexpress.com\/a-740003.html."},{"key":"10.1016\/j.bbadis.2025.168143_bb1185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114385","article-title":"P2X7 receptor and the NLRP3 inflammasome: partners in crime","volume":"187","author":"Pelegrin","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb1190","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3324\/haematol.2019.243360","article-title":"P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3","volume":"106","author":"Feng","year":"2021","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.bbadis.2025.168143_bb1195","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41419-020-03058-9","article-title":"Differential sensitivity of acute myeloid leukemia cells to daunorubicin depends on P2X7A versus P2X7B receptor expression","volume":"11","author":"Pegoraro","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2025.168143_bb1200","unstructured":"MedChemExpress AZ10606120 | Dihydrochloride | P2X Receptor Antagonist | MedChemExpress. (n.d.). MedchemExpress.com. https:\/\/www.medchemexpress.com\/az10606120-dihydrochloride.html."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb1205","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11302-012-9320-9","article-title":"P2X7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells","volume":"8","author":"Gadeock","year":"2012","journal-title":"Purine. Signal"},{"key":"10.1016\/j.bbadis.2025.168143_bb1210","unstructured":"MedChemExpress | A 438079 | P2X Receptor Antagonist | MedChemExpress. (n.d.). MedchemExpress.com. https:\/\/www.medchemexpress.com\/a-438079.html."},{"key":"10.1016\/j.bbadis.2025.168143_bb1215","unstructured":"Chemical Book | KN-62 | 127191-97-3. (n.d.). https:\/\/www.chemicalbook.com\/ChemicalProductProperty_EN_CB8443368.html."},{"issue":"Supplement 1","key":"10.1016\/j.bbadis.2025.168143_bb1220","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1182\/blood-2023-185510","article-title":"HDAC inhibitor synergizes with GL-V9, a derivative of Wogonin, to suppress acute myeloid leukemia by downregulating ESPL1 and PLK4","volume":"142","author":"Yang","year":"2023","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb1225","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.7150\/thno.46873","article-title":"Inhibitory effect of PPAR\u03b3 on NLRP3 inflammasome activation","volume":"11","author":"Yang","year":"2021","journal-title":"Theranostics"},{"issue":"21","key":"10.1016\/j.bbadis.2025.168143_bb1230","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.3390\/molecules25215033","article-title":"The synthetic flavonoid derivative GL-V9 induces apoptosis and autophagy in cutaneous squamous cell carcinoma via suppressing AKT-regulated HK2 and MTOR signals","volume":"25","author":"Zhu","year":"2020","journal-title":"Molecules"},{"issue":"28","key":"10.1016\/j.bbadis.2025.168143_bb1235","doi-asserted-by":"crossref","first-page":"26291","DOI":"10.18632\/oncotarget.4657","article-title":"GL-V9, a new synthetic flavonoid derivative, ameliorates DSS-induced colitis against oxidative stress by up-regulating Trx-1 expression via activation of AMPK\/FOXO3a pathway","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"},{"issue":"Supplement 1","key":"10.1016\/j.bbadis.2025.168143_bb1240","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1182\/blood-2023-186141","article-title":"A novel natural derivative GL-V9 inducing mitotic catastrophe and displaying a synergistic anti-tumor effect with EZH2 inhibitor in acute myeloid leukemia","volume":"142","author":"Yang","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2025.168143_bb1245","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41408-021-00547-8","article-title":"Therapeutic targeting of the inflammasome in myeloid malignancies","volume":"11","author":"Chakraborty","year":"2021","journal-title":"Blood Cancer J."},{"issue":"10","key":"10.1016\/j.bbadis.2025.168143_bb1250","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/leu.2017.21","article-title":"Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858","volume":"31","author":"Eksioglu","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.bbadis.2025.168143_bb1255","first-page":"2638","article-title":"A phase 2 study of Actinium-225 (225Ac)-Lintuzumab in older patients with previously untreated acute myeloid leukemia (AML) unfit for intensive chemotherapy","volume":"130","author":"Finn","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bbadis.2025.168143_bb1260","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.ymthe.2022.02.005","article-title":"Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33\/CD3 T cell engager, ex vivo in MDS and melanoma","volume":"30","author":"Cheng","year":"2022","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.bbadis.2025.168143_bb1265","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.clml.2019.05.008","article-title":"Clinical experience with ibrutinib alone or in combination with either cytarabine or azacitidine in patients with acute myeloid leukemia","volume":"19","author":"Cortes","year":"2019","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.bbadis.2025.168143_bb1270","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1756-8722-6-59","article-title":"Ibrutinib and novel BTK inhibitors in clinical development","volume":"6","author":"Akinleye","year":"2013","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb1275","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI128322","article-title":"Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1\u03b2-mediated colitis","volume":"130","author":"Mao","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168143_bb1280","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jaci.2017.01.017","article-title":"Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase","volume":"140","author":"Liu","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"19","key":"10.1016\/j.bbadis.2025.168143_bb1285","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1111\/bph.15182","article-title":"Inhibition of Bruton\u2019s TK regulates macrophage NF-\u03baB and NLRP3 inflammasome activation in metabolic inflammation","volume":"177","author":"Purvis","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.168143_bb1290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114861","article-title":"Luxeptinib disables NLRP3 inflammasome-mediated IL-1\u03b2 release and pathways required for secretion of inflammatory cytokines IL-6 and TNF\u03b1","volume":"195","author":"Sonowal","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.168143_bb1295","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.1015500","article-title":"Role of AMPK in autophagy","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Physiol."},{"issue":"36","key":"10.1016\/j.bbadis.2025.168143_bb1300","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1038\/onc.2012.599","article-title":"Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy","volume":"32","author":"Shortt","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2025.168143_bb1305","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155574","article-title":"Thalidomide reduces glycerol-induced acute kidney injury by inhibition of NF-\u03baB, NLRP3 inflammasome, COX-2 and inflammatory cytokines","volume":"144","author":"Amirshahrokhi","year":"2021","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.bbadis.2025.168143_bb1310","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.4049\/jimmunol.0900476","article-title":"Thalidomide inhibits activation of caspase-1","volume":"183","author":"Keller","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb1315","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-023-01558-z","article-title":"An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications","volume":"9","author":"Jiang","year":"2023","journal-title":"Cell Death Discov."},{"issue":"2","key":"10.1016\/j.bbadis.2025.168143_bb1320","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4049\/jimmunol.1301434","article-title":"Arsenic trioxide and other arsenical compounds inhibit the NLRP1, NLRP3, and NAIP5\/NLRC4 inflammasomes","volume":"192","author":"Maier","year":"2013","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.bbadis.2025.168143_bb1325","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-1004-0","article-title":"Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway","volume":"9","author":"Qiu","year":"2018","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.bbadis.2025.168143_bb1330","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1021\/acs.jafc.8b00035","article-title":"Pharmacokinetics and bioavailability of the isoflavones formononetin and ononin and their in vitro absorption in ussing chamber and CACO-2 cell models","volume":"66","author":"Luo","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbadis.2025.168143_bb1335","first-page":"1","article-title":"Bioavailability enhancement of formononetin by incorporation of natural bioenhancer in phospholipid complex","author":"Agarwal","year":"2024","journal-title":"Pharm. Dev. Technol."},{"issue":"11","key":"10.1016\/j.bbadis.2025.168143_bb1340","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3390\/biom13111575","article-title":"8-Hydroxydaidzein induces apoptosis and inhibits AML-associated gene expression in U-937 cells: potential phytochemical for AML treatment","volume":"13","author":"Wu","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbadis.2025.168143_bb1345","article-title":"Oridonin: a review of its pharmacology, pharmacokinetics and toxicity","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb1350","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13318-021-00736-7","article-title":"Andrographis paniculata formulations: impact on diterpene lactone oral bioavailability","volume":"47","author":"Damasceno","year":"2021","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.bbadis.2025.168143_bb1355","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.952660","article-title":"A comprehensive review on disposition kinetics and dosage of oral administration of Andrographis paniculata, an alternative herbal medicine, in co-treatment of coronavirus disease","volume":"13","author":"Songvut","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbadis.2025.168143_bb1360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139657","article-title":"Andrographolide analogue induces apoptosis and autophagy mediated cell death in U937 cells by inhibition of PI3K\/AKT\/MTOR pathway","volume":"10","author":"Kumar","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bbadis.2025.168143_bb1365","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.3390\/ijms9112265","article-title":"Ponicidin inhibits monocytic leukemia cell growth by induction of apoptosis","volume":"9","author":"Liu","year":"2008","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.168143_bb1370","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.659720","article-title":"Jiyuan oridonin A overcomes differentiation blockade in acute myeloid leukemia cells with MLL rearrangements via multiple signaling pathways","volume":"11","author":"Qu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2025.168143_bb1375","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.bioorg.2019.03.056","article-title":"Design and synthesis of parthenolide-SAHA hybrids for intervention of drug-resistant acute myeloid leukemia","volume":"87","author":"Ge","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbadis.2025.168143_bb1380","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejmech.2016.12.044","article-title":"Synthesis and anti-acute myeloid leukemia activity of C-14 modified parthenolide derivatives","volume":"127","author":"Yang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bbadis.2025.168143_bb1385","doi-asserted-by":"crossref","first-page":"38990","DOI":"10.18632\/oncotarget.17166","article-title":"Antineoplastic effects of CPPTL via the ROS\/JNK pathway in acute myeloid leukemia","volume":"8","author":"Gao","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb1390","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1080\/14756366.2018.1490734","article-title":"Synthesis and biological evaluation of dithiocarbamate esters of parthenolide as potential anti-acute myelogenous leukaemia agents","volume":"33","author":"Ding","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"13","key":"10.1016\/j.bbadis.2025.168143_bb1395","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1182\/blood-2007-05-090621","article-title":"An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells","volume":"110","author":"Guzman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2025.168143_bb1400","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jff.2018.04.056","article-title":"The protective effects of mangiferin on metabolic and organs functions in the adolescent rat model of alcohol abuse","volume":"46","author":"Chu","year":"2018","journal-title":"J. Funct. Foods"},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb1405","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/biof.1308","article-title":"Mangiferin: a review of sources and interventions for biological activities","volume":"42","author":"Jyotshna","year":"2016","journal-title":"BioFactors"},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb1410","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.176","article-title":"Disulfiram\/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-\u03baB and Nrf2","volume":"8","author":"Xu","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2025.168143_bb1415","article-title":"Wnt\/\u03b2-catenin inhibition by CWP232291 as a novel therapeutic strategy in ovarian Cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"issue":"7696","key":"10.1016\/j.bbadis.2025.168143_bb1420","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature25795","article-title":"Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours","volume":"555","author":"Ma","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bbadis.2025.168143_bb1425","first-page":"1931","article-title":"Pharmacokinetics and bioavailability study of polydatin in rat plasma by using a LC\u2013MS\/MS method","volume":"27","author":"Ding","year":"2014","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.bbadis.2025.168143_bb1430","article-title":"The prognostic impact of K-RAS mutations in adult acute myeloid leukemia patients treated with high-dose cytarabine","volume":"115","author":"Ahmad","year":"2011","journal-title":"Onco. Targets Ther."},{"issue":"6","key":"10.1016\/j.bbadis.2025.168143_bb1435","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood.V83.6.1603.bloodjournal8361603","article-title":"Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia","volume":"83","author":"Neubauer","year":"1994","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bbadis.2025.168143_bb1440","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.gendis.2021.12.006","article-title":"Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: therapeutic potential for liver fibrosis","volume":"10","author":"Charan","year":"2022","journal-title":"Genes Dis."},{"issue":"12","key":"10.1016\/j.bbadis.2025.168143_bb1445","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/CM9.0000000000002909","article-title":"Disulfiram: a novel repurposed drug for cancer therapy","volume":"137","author":"Zeng","year":"2024","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bbadis.2025.168143_bb1450","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.741316","article-title":"Recent advances in repurposing disulfiram and disulfiram derivatives as copper-dependent anticancer agents","volume":"8","author":"Kannappan","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb1455","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02663-8","article-title":"COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis","volume":"42","author":"Hancock","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb1460","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53078-5","article-title":"Understanding allosteric interactions in hMLKL protein that modulate necroptosis and its inhibition","volume":"9","author":"Bansal","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bbadis.2025.168143_bb1465","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2174\/0929867322666141212120926","article-title":"Involvement of the P2X7 purinergic receptor in inflammation: an update of antagonists series since 2009 and their promising therapeutic potential","volume":"22","author":"Baudelet","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"16","key":"10.1016\/j.bbadis.2025.168143_bb1470","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1016\/j.bmcl.2016.06.048","article-title":"The evolution of P2X7 antagonists with a focus on CNS indications","volume":"26","author":"Rech","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbadis.2025.168143_bb1475","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-0716-2384-8_2","article-title":"Agonists, antagonists, and modulators of P2X7 receptors","author":"M\u00fcller","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"15","key":"10.1016\/j.bbadis.2025.168143_bb1480","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.7150\/jca.58710","article-title":"Flavonoid GL-V9 suppresses invasion and migration of human colorectal cancer cells by inhibiting PI3K\/Akt and MMP-2\/9 signaling","volume":"12","author":"Gu","year":"2021","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb1485","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1375640","article-title":"Small molecule GL-V9 protects against colitis-associated colorectal cancer by limiting NLRP3 inflammasome through autophagy","volume":"7","author":"Zhao","year":"2017","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb1490","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/cbdd.14311","article-title":"A review of recent advancements in Actinium-225 labeled compounds and biomolecules for therapeutic purposes","volume":"102","author":"Hassan","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bbadis.2025.168143_bb1495","doi-asserted-by":"crossref","unstructured":"Zhang, A., & Qiu, S. (n.d.). Advances in RAR\u03b1 fusion genes in acute promyelocytic leukemia. Exp. Hematol. doi:https:\/\/doi.org\/10.1016\/j.exphem.2025.104822.","DOI":"10.1016\/j.exphem.2025.104822"},{"key":"10.1016\/j.bbadis.2025.168143_bb1500","author":"Alimoghaddam"},{"key":"10.1016\/j.bbadis.2025.168143_bb1505","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1534686","article-title":"Parthenolide: pioneering new frontiers in hematological malignancies","volume":"16","author":"Zarei","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb1510","doi-asserted-by":"crossref","first-page":"23882","DOI":"10.1038\/s41598-024-74168-z","article-title":"Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia","volume":"14","author":"De Macedo","year":"2024","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bbadis.2025.168143_bb1515","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202154262","article-title":"NPM1 ablation induces HSC aging and inflammation to develop myelodysplastic syndrome exacerbated by p53 loss","volume":"23","author":"Morganti","year":"2022","journal-title":"EMBO Rep."},{"issue":"8","key":"10.1016\/j.bbadis.2025.168143_bb1520","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168143_bb1525","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101461","article-title":"Isolates of Salmonella typhimurium circumvent NLRP3 inflammasome recognition in macrophages during the chronic phase of infection","volume":"298","author":"Cai","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.168143_bb1530","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3389\/fimmu.2020.01444","article-title":"NLRP3 inflammasome activation in cancer: a double-edged sword","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2025.168143_bb1535","article-title":"Andrographolide, a natural anti-inflammatory agent: an update","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925004934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925004934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:27:11Z","timestamp":1769506031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925004934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":307,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0925443925004934"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.168143","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the NLRP3 inflammasome signalling in acute myeloid leukemia: Mechanisms, therapeutics, and future directions","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.168143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168143"}}